Telomere-driven diseases and telomere-targeting therapies
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
Telomeres, the protective ends of linear chromosomes, shorten throughout an individual’s lifetime. Telomere shortening is proposed to be a primary molecular cause of aging. Short telomeres block the proliferative capacity of stem cells, affecting their potential to regenerate tissues, and trigger the development of age-associated diseases. Mutations in telomere maintenance genes are associated with pathologies referred to as telomere syndromes, including Hoyeraal-Hreidarsson syndrome, dyskeratosis congenita, pulmonary fibrosis, aplastic anemia, and liver fibrosis. Telomere shortening induces chromosomal instability that, in the absence of functional tumor suppressor genes, can contribute to tumorigenesis. In addition, mutations in telomere length maintenance genes and in shelterin components, the protein complex that protects telomeres, have been found to be associated with different types of cancer. These observations have encouraged the development of therapeutic strategies to treat and prevent telomere-associated diseases, namely aging-related diseases, including cancer. Here we review the molecular mechanisms underlying telomere-driven diseases and highlight recent advances in the preclinical development of telomere-targeted therapies using mouse models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therapeutic benefits have been observed for AAV-mediated delivery of TERT in animal models of aplastic anaemia, IPF and Alzheimer’s disease164,191.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [191]
Experimental — accuracy not yet measuredIn the citing paper
“Genetic defects in telomere maintenance cause human telomeropathies, including dyskeratosis congenita, aplastic anemia, and pulmonary and liver disease exhibiting multiple progeroid features15.”
From The central role of DNA damage in the ageing process (2021) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 3×
“Telomeres shorten progressively throughout an individual’s lifetime (Cawthon et al., 2003; López-Otín et al., 2013; Sanders and Newman, 2013).”
BackgroundSelf-citationSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 3×
“Indeed, ∼90% of human cancers present telomerase activity (Kim et al., 1994).”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 1×
“MC is driven by a complex and poorly understood signaling cascade that antecedes apoptosis, necrosis, senescence, or autophagy (Levine and Kroemer, 2008; Vitale et al., 2011).”
BackgroundTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 2×
“…to counteract telomere attrition associated with cell division throughout life, and therefore telomeres shorten with age in vitro and in vivo (Harley et al., 1990; Hastie et al., 1990; Lindsey et al., 1991; Collado et al., 2007; Liu et al., 2007; Flores et al., 2008; Marion et al., 2009).”
BackgroundAutophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 2×
“1 C; Greider and Blackburn, 1985).”
BackgroundShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“1 C; de Lange, 2005; Martínez and Blasco, 2010, 2011).”
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 2×
“1, A and B; Griffith et al., 1999; Doksani et al., 2013).”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · cited 1×
“…the study of telomerase-deficient mice, which show premature aging phenotypes in both lowproliferating (heart, brain) and high-proliferating compartments (bone marrow [BM], gut, skin, and testis; Blasco et al., 1997; Lee et al., 1998; Herrera et al., 1999; Leri et al., 2003; Ferrón et al., 2004).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Bär, 2016, F1000 Res, 89
Cited by
Items 201–255 of 255
Early‐life liver cirrhosis and variable clinical presentation in telomere disease
Faingelernt, Y., Nassar, R., Ling, G., Kodman, Y., Feuerstein, T., & Yerushalmi, B. (2022) · Acta Paediatrica · doi:10.1111/apa.16539 · Cited by 2
Exploring the Transcriptome Dynamics of In Vivo Theileria annulata Infection in Crossbred Cattle
Ahlawat, S., Choudhary, V., Arora, R., Kumar, A., Kaur, M., Chhabra, P., & Vijh, R. K. (2022) · Genes · doi:10.3390/genes14091663 · Cited by 3
“These enriched pathways suggest the maintenance of chromatin integrity, which may play a protective role in the host cell [31].”
BackgroundRinnerthaler, M., & Richter, K. (2018) · InTech eBooks · doi:10.5772/intechopen.76246 · Cited by 3
“In addition, short telomeres have an impact on gene expression through telomere position effects on nearby genes [37].”
BackgroundTelomerase Prevents Emphysema in Old Mice by Sustaining Subpopulations of Endothelial and AT2 CellsPreprint
Breau, M., Cayrou, C., Churikov, D., Fouillade, C., Curras-Alonso, S., Bauwens, S., Jourquin, F., Braud, L., FIORE, F., Castellano, R., et al. (2021) · Research Square · doi:10.1101/2021.01.07.425708 · Cited by 3
Kalmykova, A. I. (2024) · Russian Journal of Developmental Biology · doi:10.1134/s106236042470005x · Cited by 2
“Therapeutic approaches are being actively developed to inhibit telomerase in cancer cells and to reactivate it in normal cells to prevent age-dependent disorders and promote tissue renewal (Martínez and Blasco, 2017; Shay and Wright, 2019; Gao and Pickett, 2022).”
Hanley, S. M., Schutte, N. S., Bellamy, J., & Denham, J. (2025) · Journal of Intellectual Disability Research · doi:10.1111/jir.13244 · Cited by 1
“…gene therapies are currently demonstrating promise in treating age-related diseases in rodent studies (Bar et al. 2016; Bernardes De Jesus et al. 2012; Martinez and Blasco 2017; Povedano et al. 2018), including heart (Yeh et al. 2019) and neurodegenerative diseases (Whittemore et al. 2019).”
Multifactorial conceptual model of cancer-related accelerated aging
Lh, M., Weiss, S. M., Ritchie, C. S., Wong, M. L., Hoffmann, T. K., Wallhagen, M. L., & Miaskowski, C. A. (2026) · npj Aging · doi:10.1038/s41514-025-00328-8 · Cited by 4
“Genetic defects that result in the reduction of telomerase, an enzyme that maintains the structural integrity of telomeres, are associated with cancer and degenerative diseases (e.g., Dyskeratosis congenita) 145 .”
DNA-targeting Invader probes: discovery, principles and applications
Hrdlicka, P. J., & Everly, M. E. (2026) · RSC Chemical Biology · doi:10.1039/d5cb00286a · Cited by 2
Aging, Cancer, and Apoptosis in Animal Models and Clinical Settings
Yamamoto, K., Kurata, M., Kitagawa, M., & Hirokawa, K. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_57 · Cited by 1
Dysregulation of transcription and human diseases
Uchiumi, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818787-6.00003-5 · Cited by 1
Telomere dysfunction in some pediatric congenital and growth-related diseases
Zheng, B., & Fu, J. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1133102 · Cited by 1
“Drug action Animal model Disease Refs. no AA (105) activity of TERT by reducing tion of TERC no DC (106) elomerase activator in ne cells, and neonatal and fibroblasts mice Senescence (107) ression of TERT in vitro, it ed into animal models mice AD (108) ression of TERT in vitro, it ed into animal models mice osteoporo…”
BackgroundACCELERATED POPULATION AGING AS A CONSEQUENCE OF THE COVID-19 PANDEMIC (review)
Михайлович, К. И., Сагинбаев, У. Р., Рукавишникова, С. А., & Ахмедов, Т. А. (2023) · Успехи геронтологии · doi:10.34922/ae.2023.36.4.005 · Cited by 2
Nunes, B. D. M., Oliveira, M. B. N., Dantas, F. J. D. S., & da Fonseca, A. D. S. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04520-w · Cited by 1
“…based on low-power lasers and LEDs as well as for developing new clinical protocols targeting telo - mere maintenance involved in PBM-induced therapeutic effects. clinical outcomes such as bad response to radio and chemo - therapy, as well as some cancers and age-related diseases [ 21–23 ].”
Portillo, A. M., García-Velasco, J. A., & Varela, E. (2025) · Biosystems · doi:10.1016/j.biosystems.2025.105577 · Cited by 1
“The cell has a certain maximum and minimum mean telomeric length, being the Hayflick limit the minimal telomeric length that does not permit replication (Hayflick and Moorhead, 1961) leading to cell senescence or apoptosis (Martínez and Blasco, 2017).”
Genetics of premature ovarian insufficiency
Serna, J., Varela, E., & García-Velasco, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816561-4.00011-9 · Cited by 2
From cellular senescence towards age-related macular degeneration: the role of telomeres
Moshetova, L. K., Abramova, O. I., Turkina, K. I., Dmitrenko, O., & Karpova, N. S. (2020) · Russian Journal of Clinical Ophthalmology · doi:10.32364/2311-7729-2020-20-3-148-151 · Cited by 1
A INFLUÊNCIA DA NUTRIÇÃO NO COMPRIMENTO DE TELÔMERO EM IDOSOS
de Souza, M. I. C., Guilherme, M. M., Chaebo, R. F. P., Tonsic, B. R., & Prado, R. F. D. (2023) · Anais do II Congresso Brasileiro de Saúde Pública On-line · doi:10.51161/conbrasp2023/25172 · Cited by 1
Induction of telomerase in p21-positive cells counteracts capillaries rarefaction in aging mice lungPreprint
Lipskaia, L., Breau, M., Cayrou, C., Churikov, D., Braud, L., Fouillade, C., Curras-Alonso, S., Bauwens, S., Jourquin, F., FIORE, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.27.514005 · Cited by 2
“Because TERT may reverse these processes, TERT-based gene therapy (Martínez & Blasco, 2017) may be clinically beneficial to treat COPD.”
BackgroundTelomeres and telomere dysfunctions
Dobre, E.-G., Dinescu, S., & Costache, M. (2018) · Reviews in Biological and Biomedical Sciences · doi:10.31178/rbbs.2019.2.1.3
Modifiability of Longevity and Quality-of-Life Predictors of Older Adults
Stephens, J., Fiedler, M., Lidell, M., & Gatchel, R. J. (2018) · Handbooks in health, work, and disability · doi:10.1007/978-3-030-03916-5_2
The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension
Torrisi, S. E., Fuhrmann, V., Skowasch, D., & Kreuter, M. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10015119
Centromere and telomere dynamics in humans
Anitha, A., Thanseem, I., & Vasu, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817819-5.00010-3 · Cited by 2
Leukocyte telomere length associated with glioma risk and survival
Shen, J., Song, R., Ye, Y., Gong, Y., & Zhao, H. (2020) · Aging and Cancer · doi:10.1002/aac2.12020
Melhoramento da estabilidade física do pró-fármaco 5-Fluorocitosina via cocristalização
Souza, M. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.76.2019.tde-07052019-110715 · Cited by 1
Expression of telomeric repeat binding factor 2 (TERF2) in childhood acute lymphoblastic leukemia
Vengidasan, L., Choong, S. S., Chen, K., & Ibrahim, K. (2021) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2021.029.2.10
“TERF2 is over-expressed in several human tumors, such as skin cancer (Biroccio et al., 2006; Martínez and Blasco, 2017), hepatocarcinoma (Oh et al., 2005), carcinoma of the lung (Nakanishi et al., 2003) and breast carcinomas (Diehl et al., 2011; Nijjar et al., 2005) as well as colon cancer (Dong et…”
Aging, Cancer, and Apoptosis in Animal Models and Clinical Settings
Yamamoto, K., Kurata, M., Kitagawa, M., & Hirokawa, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_57-1
Park, H. S., Son, B. R., & Kwon, J. (2022) · Laboratory Medicine · doi:10.1093/labmed/lmac100
The landscape of the repeated sequences in the human genome
Uchiumi, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818787-6.00011-4
CHANGES IN TELOMERE LENGTH IN LEUKOCYTES OF MALE RHESUS MACAQUES OF DIFFERENT AGES
Тимина, М. Ф., Павлова, Л. Е., Kirgintsev, R. M., & Анзорович, А. А. (2024) · Успехи геронтологии · doi:10.34922/ae.2023.36.6.013
The Different Aspects of Telomerase Inhibitors in Cancer Treatment
Radmehr, A., & Safdarian, A. R. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_480
Function and inhibition of the DNA repair enzyme SNM1A
Berney, M., Ferguson, S., & McGouran, J. F. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108225
miR-23a-mediated TRF2 repression in CD4 T cells from PLWH
Nguyen, L. N., Zhao, J., Pyburn, J. S., Wang, L., Schank, M., Banik, P., Hill, A. C., Wu, X. Y., Zhang, Y., Ning, S., et al. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.04.003
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085867
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085864
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085858
Wang, C., Songyang, Z., & Huang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15085861
Cognitive dysfunction resulting in telomere degradation: the potential of probiotics as a supplement
Sekar, J. M., Prabhu, V., Subramanian, P., Nehru, M., & Subbiah, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27622-4.00002-x
Uyen, L. T. H., Duyen, V. T. C., & Truong, P. L. (2026) · RSC Advances · doi:10.1039/d5ra08471g
Tissue morphology predicts telomere shortening in human tissues
Yadav, A., Alvarez, K., Adeleye, A., Wang, Y. X., Jackson, M., & Sinha, S. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101336 · Cited by 2
Investigation into the role of human RAP1 in telomere protection
Lototska, L. (2018) · theses.fr (ABES) · doi:10.70675/206c00d7zf1c8z46bcz8d20zb2289991e250
Billard, P. (2021) · theses.fr (ABES) · doi:10.70675/7d145f6az2700z4c8bzad56z3286d493fb31
Amélioration de la régénération cellulaire et tissulaire au cours du vieillissement
Alle, Q. (2020) · theses.fr (ABES) · doi:10.70675/932e617bzcb45z4332z8badzfda37d5299a8
Relations between aortic valve calcification and telomere lenght dynamics
Saraieva, I. (2020) · theses.fr (ABES) · doi:10.70675/c98af202z0365z444bz8ee1z337555d97246
Low-energy photoionization of guanine quadruplexes
Balanikas, E. (2021) · theses.fr (ABES) · doi:10.70675/4548b207z217bz431cz8079zfaabaa78fb55 · Cited by 1
Donald Barceloux MD, F., & Robert B. Palmer PhD, D. (2026) · Medical Toxicology · doi:10.1002/9781119872979.ch47
Immunotherapy for senescent cell clearance: Hallmarks, strategies and translational challenges
Zhang, W., Chen, S., & Zhuang, X. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103174
Innovative Treatment in Aplastic Anemia and Other Inherited Bone Marrow Failure Syndromes
Mishra, K., & Kapoor, R. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02462-z
Zhan, H., Zheng, R., Li, Y., Liu, X. W., Shi, Y., Chen, R., Hou, Q., Huang, H. F., & Lin, M. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.034
“It is now clear that telomere shortening is not merely a marker of aging but a dynamic and influential driver of disease pathogenesis across a spectrum of conditions, including interstitial lung diseases (ILD), chronic obstructive pulmonary disease (COPD), and asthma 16 — 20 .”
InfluentialWong, T. Y., Gillett, A. C., Duarte, R. R. R., Habiballa, L., Fisher, H. L., Codd, V., & Powell, T. R. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112228
Marión, R. M., González, J. C., Flores, J. M., Piñeiro-Yáñez, E., Serrano, R., & Blasco, M. A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117786 · Cited by 2
Self-citationBreaking the self-reinforcing cycle of aging: Biomaterial strategies for aged bone regeneration
Wang, Y., Chen, J., Liu, X., Pei, Y., Chen, S., & Zhou, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103348
Zhang, J., Su, W., Duan, J., Sun, Y., & Liu, B. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100262
BindingDB (2024) · UC San Diego · doi:10.7270/q2mg7tw8
Metadata
- Authors
- Martínez, P., & Blasco, M. A.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, Madrid E-28029, Spain
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2017-03-02
- Volume
- 216
- Issue
- 4
- Pages
- 875-887
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC5379954
- OpenAlex
- W2592919828
- Cited by
- 257
- References
- 148
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 22 · 2023: 21 · 2022: 33 · 2021: 43 · 2020: 38 · 2019: 21 · 2018: 33 · 2017: 13
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Spanish Ministry of Economy and Competitiveness
- Fondo Europeo de Desarrollo Regional (SAF2013-45111-R)
- European Research Council (ERC-2008-AdG/232854)
- Fundación Botín
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomeres, telomere shortening, aging, Hoyeraal-Hreidarsson syndrome, dyskeratosis congenita, pulmonary fibrosis, aplastic anemia, liver fibrosis, chromosomal instability, carcinogenesis, shelterin, telomere maintenance genes, cancer, stem cell proliferation, mouse model
- MeSH terms
- Aging, Animals, Cell Transformation, Neoplastic, Fetal Growth Retardation, Humans, Intellectual Disability, Microcephaly, Mutation, Neoplasms, Telomere, Telomerase, Dyskeratosis Congenita, Chromosomal Instability, Molecular Targeted Therapy, Telomere Homeostasis, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.